References
- Morin, P., Sparks, A., Korinek, V., Barker, N., et al(1997) activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 275; 1787-1790.
- Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525–532
- Smith KJ, Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A 1993; 90: 2846–2850.
- Miyashiro I, Senda T, Matsumine A, et al. Subcellular localization of the APC protein: immunoelectron microscopic study of the association of the APC protein with catenin. Oncogene 1995; 11: 89–96
- Lynch HT, Smyrk T, Lynch JF. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome). Int J Cancer 1996; 69: 38–43.
- Bhattacharyya NP, Skandalis A, Ganesh A, et al. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci U S A 1994; 91: 6319–6323
- Lynch, JP, Hoops, TC. The genetic pathogenesis of colorectal cancer. Hematol Oncol Clin North Am 2002; 16:775
- Eshleman JR, Lang EZ, Bowerfind GK, et al. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene 1995; 10: 33–37.
- Shibata D, Peinado MA, Ionov Y, et al. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet 1994; 6: 273–281
- Pretlow TP, O Riordan MA, Pretlow TG, Stellato TA. Abberant crypts in human colonic mucosa:putative preneoplastic lesions. J Cell Biochem 1992;16G:55-62.
- Takayama T, Katsuki Y, Oho M et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998;339;1277-84.
- Yamada Y, Yoshimi N, Hirose Y et al. Frequent bcatenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res 2000;60;3323-7.
- Caderni G, femia AP, Giannini A, et al. Identification of mucin depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 2003; 63:2388-92.
- Femia AP, Giannini A, fazi M,et al. Identification of mucin depleted foci in the human colon. Cancer Prev Rev 2008;1:562-7.
- Mori H, Hata K, Yamada Y, Kuno T, Hara A. Significance and role of early – lesions in axperimental coloractal carcinogenesis. Chem Biol Interact 2005;155:1-9.
- Bird RP, Good CK. The significance of aberant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 2000;112/113:395-402.
- Kudo S., Hirota S., et al. Colorectal tumors and pit pattern. J. Clin. Pathol., 1994;47:880-885.
- Kudo S., Rubio C.A., Teixeira C.R., and Kogue E. Pit pattern in colorectal neoplasia:endoscopic magnifying view. Endoscopy 2001;33:367-373.
- Hamilton S., and Aaltonen L. Tumors of Digestive System 2000;IARC Sientific Press, IARC, Lyon.
- Riggleman B., Scheld P.,and Wieschaus E. Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless. Cell, 1990;63:549-560.
- Hart M., Concordet J.P., Lassot I.,et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr. Bio, 1999;9:207-210.
- Aberle H., Bauer A., Stappert J.,and Kemler R. Beta –catenin is a target for the ubiquitin-proteasone pathway. EMBO J., 1997;16:3797-3804.
- He T., Sparks A., Vogelstein B., and Kinzler K. Constitutive transcriptional activation by a beta-carenin-Tcf complex in APC-carcinoma. Science, 1997;275:1784-1787.
- Tetsu O., and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 1999;281:1509-1512.
- Vogelstein B., and Kinzler K. The genetic Basis of Human Cancer.1998. McGraw-Hill, New York.
- Takahashi M., Fuduka K., and Wakabayashi K. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 1998;58:42-46.
- Yamada Y., Yoshimi N., Hirose Y, et al. Sequential analysis of morphological and biological properties of beta-catenin-acumulated crypts,probable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Rev 2001;61:1874-1878.
- Yamada Y., Yoshimi N., Hara A., and Mori H. Frequent beta-catenin gene mutations and accumulations of the protein in the putative pre-neoplastic lesions lacking macroscopic abberant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 2000;60:3323-3327.
- Wilson CL., Heppner KJ., and Matrisian L.M. Intestinal tumorigenesis is suppressed in mice laking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA 1997;94:1402-1407.
- Yamada Y., Oyama T.,and Mori H. Beta-catenin mutation is selectedduring malignant transformation in colon carcinogenesis. Carcinogenesis, 2003;24:91-97.
- Johnson L., Mercer K.,and Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature, 2001;410:1111-1116.
- Delapierre, F. et al. (1981) Preneoplastic changes in epithelium and mesenchyme in colon of rats treated with 1,2-dimethylhydrazine. Cancer Detect. Prev., 4, 429–437.
- Wargovich, M.J. et al. (1983) Early histopathologic events to evolution of colon cancer in C57BL/6 and CF1 mice treated with 1,2-dimethylhydrazine. J. Natl Cancer Inst., 71, 125–31.
- Bird, R.P. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147–151.
- Pretlow, T.P. et al. (1993) Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole mounts of colons from F344 rats treated with carcinogen. Am. J. Pathol., 142, 1695–1700.
- Tsukamoto, T. et al. (2001) Hexosaminidase-altered aberrant crypts, carrying decreased hexosaminidase alpha and beta subunit mRNAs, in colon of 1,2-dimethylhydrazine-treated rats. Jpn. J. Cancer Res., 92, 109–118.
- Tsukamoto, T. et al. (2006) Three-dimensional analysis of isolated hexosaminidase-altered aberrant crypts from colons of 1,2-dimethylhydrazinetreated rats. Exp. Toxicol. Pathol., 57, 283–289.
- Hata, K. et al. (2004) Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Sci., 95, 316–320.
- Caderni, G. et al. (2003) Identification of mucin-depleted foci in the unsanctioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res., 63, 2388–2392.
- Paulsen, J.E. et al. (2000) Identification and quantification of aberrant crypt foci in the colon of Min mice—a murine model of familial adenomatous polyposis. Scand. J. Gastroenterol., 35, 534–539.